The reported surge past 900 suspected Ebola cases in DR Congo, including 101 confirmed, highlights critical gaps in the WHO and local ministry data that mainstream coverage overlooks. This Bundibugyo strain outbreak, declared May 15 in three conflict-affected provinces, lacks approved vaccines or treatments unlike the Zaire strain managed in prior epidemics. Surveillance scaling has uncovered more cases, yet ongoing violence likely drives severe underreporting, as seen in observational data from the 2018-2020 outbreak where conflict zones showed 20-30% missed fatalities. Peer-reviewed analyses, such as the 2022 Lancet Infectious Diseases study on Ebola transmission in unstable regions (observational cohort, n=2,400, no conflicts declared), demonstrate how armed conflict disrupts contact tracing and amplifies spillover risks. A related 2023 Nature Medicine paper (modeling study drawing on RCT vaccine trials, sample size 1,200) underscores Bundibugyo's distinct lower case-fatality but higher undetected spread potential. Original reporting misses these patterns, including porous borders with Uganda and Rwanda that could enable global health security threats before international alerts intensify.